Workflow
Aytu BioPharma(AYTU) - 2025 Q4 - Earnings Call Transcript

Aytu Biopharma (NasdaqCM:AYTU) Q4 2025 Earnings Call September 23, 2025 04:30 PM ET Company ParticipantsRobert Blum - Managing DirectorRyan Selhorn - CFOJosh Disbrow - Co-founder, CEO, and DirectorConference Call ParticipantsNaz Rahman - VP and Biopharmaceuticals Equity Research AnalystEd Woo - Senior Research AnalystThomas Flaten - Senior Research AnalystOperatorGreetings. Welcome to the Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter in Operational and Financial Results on September 23, ...